Outpatient management after transplantation;Management nach transplantation

Therapeutische Umschau

Volumn 62, Issue 7, 2005, Pages 487-501

  Mayr, Michael ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCITRIOL; CERTICANE; CYCLOSPORIN A; DIPHTHERIA VACCINE; EVEROLIMUS; HAEMOPHILUS INFLUENZAE VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; IMMUNOSUPPRESSIVE AGENT; INFLUENZA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; RAPAMYCIN; STEROID; TACROLIMUS; TETANUS TOXOID; UNCLASSIFIED DRUG;

ACNE; ANEMIA; ANGIONEUROTIC EDEMA; ARTHRALGIA; BONE DISEASE; BONE NECROSIS; CARDIOVASCULAR RISK; CATARACT; CUSHING DISEASE; DIABETES MELLITUS; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DYSESTHESIA; DYSLIPIDEMIA; DYSPEPSIA; EPSTEIN BARR VIRUS; GINGIVA HYPERPLASIA; GRAFT REJECTION; HALLUCINATION; HEPATITIS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HUMAN; HUMAN HERPESVIRUS 8; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRICHOSIS; HYPERURICEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFLUENZA VACCINATION; KAPOSI SARCOMA; LEUKOPENIA; LIVER CELL CARCINOMA; LUNG DISEASE; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MELANOMA; MICROANGIOPATHY; MORBIDITY; MORTALITY; MUSCLE HYPERTONIA; MYOPATHY; NEPHROTOXICITY; NEUROTOXICITY; ORGAN TRANSPLANTATION; OSTEOPOROSIS; OUTPATIENT CARE; PANCREATITIS; PARESTHESIA; PSYCHOSIS; REVIEW; SIDE EFFECT; SURVIVAL RATE; SURVIVAL TIME; TETANUS PROPHYLAXIS; THROMBOCYTOPENIA; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREMOR; VACCINATION; WART VIRUS;

AMBULATORY CARE; BONE DISEASES; CARDIOVASCULAR DISEASES; GRAFT REJECTION; HUMANS; NEOPLASMS; PHYSICIAN'S PRACTICE PATTERNS; POSTOPERATIVE CARE; PRACTICE GUIDELINES; TRANSPLANTATION;

EID: 22344444154     PISSN: 00405930     EISSN: None     Source Type: Journal    
DOI: 10.1024/0040-5930.62.7.487     Document Type: Review

References (43)

1. Robertson RP. Islet transplantation as a treatment for diabetes - a work in progress. N Engl J Med 2004; 350 (7): 694-705.
2. Heisel O, Heisel R, Balshaw R, Keown P. New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am J Transplant 2004; 4 (4): 583-95.
3. Davidson J, Wilkinson A, Dantal J, Dotta F, Haller H, Hernandez D et al. New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003. Transplantation 2003; 75 (10 Suppl): SS3-24.
4. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 2002; 106 (25): 3143-421.
5. Torres A, Lorenzo V, Salido E. Calcium metabolism and skeletal problems after transplantation. J Am Soc Nephrol 2002; 13 (2): 551-8.
6. Recommendations for the prevention and treatment of glucocorticoid- induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. Arthritis Rheum 2001; 44 (7): 1496-1503.
7. Cruz DN, Brickel HM, Wysolmerski JJ, Gundberg CG, Simpson CA, Kliger AS et al. Treatment of osteoporosis and osteopenia in long-term renal transplant patients with alendronate. Am J Transplant 2002; 2 (1): 62-7.
8. Abbott KC, Oglesby RJ, Agodoa LY. Hospitalized avascular necrosis after renal transplantation in the United States. Kidney Int 2002; 62 (6): 2250-6.
9. Bozic KJ, Zurakowski D, Thornhill TS. Survivorship analysis of hips treated with core decompression for nontraumatic osteonecrosis of the femoral head. J Bone Joint Surg Am 1999; 81 (2): 200-9.
10. Morath C, Mueller M, Goldschmidt H, Schwenger V, Opelz G, Zeier M. Malignancy in renal transplantation. J Am Soc Nephrol 2004; 15 (6): 1582-8.
11. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348 (17): 1681-91.
12. Bouwes Bavinck JN, Hardie DR, Green A, Cutmore S, MacNaught A, O'Sullivan B et al. The risk of skin cancer in renal transplant recipients in Queensland, Australia. A follow-up study. Transplantation 1996; 61 (5): 715-21.
13. Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 2004; 350 (13): 1328-37.
14. Opelz G, Henderson R. Incidence of non-Hodgkin lymphoma in kidney and heart transplant recipients. Lancet 1993; 342 (8886-8887): 1514-6.
15. Andreone P, Gramenzi A, Lorenzini S, Biselli M, Cursaro C, Pileri S et al. Posttransplantation lymphoproliferative disorders. Arch Intern Med 2003; 163 (17): 1997-2004.
16. Seukeran DC, Newstead CG, Cunliffe WJ. The compliance of renal transplant recipients with advice about sun protection measures. Br J Dermatol 1998; 138 (2): 301-3.
17. Kasiske BL, Vazquez MA, Harmon WE, Brown RS, Danovitch GM, Gaston RS et al. Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol 2000; 11 Suppl 15: S1-86.
18. Fishman JA, Rubin RH. Infection in organ-transplant recipients. N Engl J Med 1998; 338 (24): 1741-51.
19. Arzneimittelkompendium. 26. Auflage ed. Documed AG, 2005.
20. Steiger J. In: Gyr NE, Schoenenberger RA, Haefeli WE, editors. Internistische Notfälle. Stuttgart. New York: Georg Thieme Verlag, 2003: 171-85.
21. Penn I. Malignant melanoma in organ allograft recipients. Transplantation 1996; 61 (2): 274-8.
22. Penn I, First MR. Merkel's cell carcinoma in organ recipients: report of 41 cases. Transplantation 1999; 68 (11): 1717-21.
23. Denton MD, Magee CC, Ovuworie C, Mauiyyedi S, Pascual M, Colvin RB et al. Prevalence of renal cell carcinoma in patients with ESRD pre-transplantation: a pathologic analysis. Kidney Int 2002; 61 (6): 2201-9.
24. Doublet JD, Peraldi MN, Gattegno B, Thibault P, Sraer JD. Renal cell carcinoma of native kidneys: prospective study of 129 renal transplant patients. J Urol 1997; 158 (1): 42-4.
25. Pommer W, Bronder E, Klimpel A, Helmert U, Greiser E, Molzahn M. Urothelial cancer at different tumour sites: role of smoking and habitual intake of analgesics and laxatives. Results of the Berlin Urothelial Cancer Study. Nephrol Dial Transplant 1999; 14 (12): 2892-7.
26. Maurer T, Izakovic J, Bircher A. Merkblatt zum Sonnenschutz für Transplantatempfänger. Transplantationsimmunologie und Nephrologie Universtitätsspital Basel. 2005.
27. Blumberg EA, Fitzpatrick J, Stutman PC, Hayden FG, Brozena SC. Safety of influenza vaccine in heart transplant recipients. J Heart Lung Transplant 1998; 17 (11): 1075-80.
28. Burbach G, Bienzle U, Stark K, Rayes N, Neuhaus R, Serke S et al. Influenza vaccination in liver transplant recipients. Transplantation 1999; 67 (5): 753-5.
29. Dengler TJ, Strnad N, Buhring I, Zimmermann R, Girgsdies O, Kubler WE et al. Differential immune response to influenza and pneumococcal vaccination in immunosuppressed patients after heart transplantation. Transplantation 1998; 66 (10): 1340-47.
30. Fraund S, Wagner D, Pethig K, Drescher J, Girgsdies OE, Haverich A. Influenza vaccination in heart transplant recipients. J Heart Lung Transplant 1999; 18 (3): 220-5.
31. Kimball P, Verbeke S, Flattery M, Rhodes C, Tolman D. Influenza vaccination does not promote cellular or humoral activation among heart transplant recipients. Transplantation 2000; 69 (11): 2449-51.
32. Sanchez-Fructuoso AI, Prats D, Naranjo P, Fernandez-Perez C, Gonzalez MJ, Mariano A et al. Influenza virus immunization effectivity in kidney transplant patients subjected to two different triple-drug therapy immunosuppression protocols: mycophenolate versus azathioprine. Transplantation 2000; 69 (3): 436-9.
33. Huzly D, Neifer S, Reinke P, Schroder K, Schonfeld C, Hofmann T et al. Routine immunizations in adult renal transplant recipients. Transplantation 1997; 63 (6): 839-45.
34. Kazancioglu R, Sever MS, Yuksel-Onel D, Eraksoy H, Yildiz A, Celik AV et al. Immunization of renal transplant recipients with pneumococcal polysaccharide vaccine. Clin Transplant 2000; 14 (1): 61-5.
35. Sever MS, Yildiz A, Eraksoy H, Badur S, Yuksel-Onel D, Gorcin B et al. Immune response to Haemophilus influenzae type B vaccination in renal transplant recipients with well-functioning allografts. Nephron 1999; 81 (1): 55-9.
36. Chalasani N, Smallwood G, Halcomb J, Fried MW, Boyer TD. Is vaccination against hepatitis B infection indicated in patients waiting for or after orthotopic liver transplantation? Liver Transpl Surg 1998; 4 (2): 128-32.
37. Dominguez M, Barcena R, Garcia M, Lopez-Sanroman A, Nuno J. Vaccination against hepatitis B virus in cirrhotic patients on liver transplant waiting list. Liver Transpl 2000; 6 (4): 440-2.
38. Duca P, Del Pont JM, D'Agostino D. Successful immune response to a recombinant hepatitis B vaccine in children after liver transplantation. J Pediatr Gastroenterol Nutr 2001; 32 (2): 168-70.
39. Engler SH, Sauer PW, Golling M, Klar EA, Benz C, Stremmel W et al. Immunogenicity of two accelerated hepatitis B vaccination protocols in liver transplant candidates. Eur J Gastroenterol Hepatol 2001; 13 (4): 363-7.
40. Jacobson IM, Jaffers G, Dienstag JL, Tolkoff-Rubin NE, Cosimi AB, Delmonico F et al. Immunogenicity of hepatitis B vaccine in renal transplant recipients. Transplantation 1985; 39 (4): 393-5.
41. Arslan M, Wiesner RH, Sievers C, Egan K, Zein NN. Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease. Liver Transpl 2001; 7 (4): 314-20.
42. Arslan M, Wiesner RH, Poterucha JJ, Zein NN. Safety and efficacy of hepatitis A vaccination in liver transplantation recipients. Transplantation 2001; 72 (2): 272-6.
43. Keeffe EB, Iwarson S, McMahon BJ, Lindsay KL, Koff RS, Manns M et al. Safety and immunogenicity of hepatitis A vaccine in patients with chronic liver disease. Hepatology 1998; 27 (3): 881-6.